Advertisement

Rheumatology International

, Volume 31, Issue 8, pp 1069–1074 | Cite as

Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting

  • Li Long
  • Ru Li
  • Yongzhe Li
  • Chaojun Hu
  • Zhanguo LiEmail author
Original Article

Abstract

The objective of this study was to search for proteomic patterns distinguishing patients with rheumatoid arthritis (RA) from healthy controls, biomarker candidates specific for early RA, and proteins reflecting disease activity, by profiling of serum proteins using magnetic bead-based (MB) separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Magnetic chemical affinity beads were used to differentially capture serum proteins prior to MALDI-TOF analysis. Seventy serum samples from patients with RA and 50 from healthy controls were analyzed. The samples were randomly allocated to the training set or test set to develop a pattern by means of decision tree algorithm. ANOVA test was utilized to search for biomarkers for early RA. Pearson correlation analysis was employed to estimate the overexpressed peaks in relation to Disease Activity Score (DAS)28. The algorithm identified a pattern based on 3 peaks (m/z 2,490, 5,910.07, 6,436.73) that, in the training set, separated patients with RA from healthy controls with a sensitivity and specificity of 87.5 and 96.7%, respectively. Blind test data indicated a sensitivity of 86.7% and specificity of 90%. The peaks of m/z 1,014.92 and 1,061.38 were raised significantly in early RA group (disease duration <12 months) compared with those in non-early RA group (disease duration ≥12 months) and healthy controls. A positive correlation was found between the intensity of peak 9,591.47 and DAS28 scores. Using MB separation followed by MALDI-TOF–MS enabled rapid diagnosis of RA according to fingerprint pattern, a method which might also help to assess disease activity and identify early RA.

Keywords

Rheumatoid arthritis MALDI-TOF Mass spectrometry Magnetic beads 

Notes

Acknowledgments

This study was supported by National Key Technology R&D Program in the 11th Five year Plan of china (2008BA159B01), as well as Medical Research and Development Capital Funds of China (2007–2009).

References

  1. 1.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  2. 2.
    Saraux A, Berthelot JM, Chales G et al (2001) Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 44:2485–2491PubMedCrossRefGoogle Scholar
  3. 3.
    Harrison BJ, Symmons DP, Barrett EM et al (1998) The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 25:2324–2330PubMedGoogle Scholar
  4. 4.
    Hulsemann JL, Zeidler H (1999) Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Ann Rheum Dis 58:278–280PubMedCrossRefGoogle Scholar
  5. 5.
    Liao KP, Batra KL, Chibnik L et al (2008) Anti-CCP revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 67:1557–1561PubMedCrossRefGoogle Scholar
  6. 6.
    Visser H, Cessie Sl, Vos K et al (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRefGoogle Scholar
  7. 7.
    Schlesier B, Mock HP (2006) Protein isolation and second-dimension electrophoretic separation. Methods Mol Biol 323:381–391PubMedGoogle Scholar
  8. 8.
    Vimalachandran D, Costello E (2004) Proteomic technologies and their application to pancreatic cancer. Expert Rev Proteomics 1(4):493–501PubMedCrossRefGoogle Scholar
  9. 9.
    Villanueva J, Philip J, Entenberg D et al (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560–1570PubMedCrossRefGoogle Scholar
  10. 10.
    Freed GL, Cazares LH, Fichandler CE et al (2008) Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 118(1):61–68PubMedCrossRefGoogle Scholar
  11. 11.
    Scott DL (2002) The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 46(2):286–290PubMedCrossRefGoogle Scholar
  12. 12.
    Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140:659–662PubMedGoogle Scholar
  13. 13.
    Prevoo ML, vant’ Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRefGoogle Scholar
  14. 14.
    Wells GA, Becker JC, Teng J, et al (2008) Validation of the disease activity score 28 (DAS28) and EULAR response criteria based on CRP against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on ESR. Ann Rheum Dis 68(6):954–960PubMedCrossRefGoogle Scholar
  15. 15.
    Zhukov TA, Johanson RA, Cantor AB et al (2003) Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 40:267–279PubMedGoogle Scholar
  16. 16.
    Won Y, Song HJ, Kang TW et al (2003) Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 3:2310–2316PubMedCrossRefGoogle Scholar
  17. 17.
    Cheng AJ, Chen LC, Chien KY et al (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51(12):2236–2244PubMedCrossRefGoogle Scholar
  18. 18.
    Peter JF, Otto AM, Wolf B (2007) Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS. J Biomol Tech 18(5):287–297PubMedGoogle Scholar
  19. 19.
    Fiedler GM, Baumann S, Leichtle A, et al (2007) Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 53(3):421–428PubMedCrossRefGoogle Scholar
  20. 20.
    de Seny D, Fillet M, Meuwis MA et al (2005) Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 52(12):3801–3812PubMedCrossRefGoogle Scholar
  21. 21.
    Liu W, Li X, Ding F, Li Y (2008) Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis. Scand J Rheumatol 37(2):94–102PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Li Long
    • 1
  • Ru Li
    • 1
  • Yongzhe Li
    • 2
  • Chaojun Hu
    • 2
  • Zhanguo Li
    • 1
    Email author
  1. 1.Department of Rheumatology and ImmunologyPeking University People’s HospitalBeijingChina
  2. 2.Department of Medicine Rheumatology and Clinical Immunology DivisionPeking Union Medical College HospitalBeijingChina

Personalised recommendations